67 per cent experts to use decentralised clinical trials in near future due to COVID-19: GlobalData Read more
INmune Bio gets US FDA nod for Phase II trial of Quellor, a sTNF inhibitor for COVID-19 treatment Read more
Empagliflozin reduced risk of death and hospitalisation for heart failure by 25 per cent in adults Read more